Stock market announcement archive

LIFE – Successfully completed four weeks of longevity trials

July 17, 2024
Bergen, Norway, 17 July 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first four week of sensor longevity trials. Reference is made to press releases 18 June 2024 when the company initiated the trials with wireless readout. The […]
Read more

Lifecare ASA: Share capital increase

July 5, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (“Lifecare” or the “Company”) on 14 June 2024 regarding the final results of the partially underwritten rights issue of new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the issuance of 1,377,572 new shares to certain bottom underwriters […]
Read more

Lifecare ASA: Mandatory notification of trade

July 2, 2024
Reference is made to the previous stock exchange announcements published by Lifecare ASA (the “Company”) regarding the completion of the Rights Issue. Hannibal Invest AS, a company closely associated with Hans Hekland, board member of the Company, has 27 June 2024 subscribed 65,599 shares at a price of NOK 1,52442 per share, as compensation for […]
Read more

LIFE: Cleanroom arrived in Hamburg

July 2, 2024
Bergen, Norway, July 2, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the cleanroom for automated production has arrived in Hamburg. Reference is made to Lifecare’s stock exchange announcement March 5, 2024, regarding placing a purchase order for cleanroom in connection with the […]
Read more

LIFE: Successfully completed first week of longevity trials

June 27, 2024
Bergen, Norway, 27 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce positive results from the first week of sensor longevity trials. Reference is made to press release 18 June 2024 when the company initiated the trials with wireless readout. Already after […]
Read more

Lifecare ASA: Share capital increase and warrants registered

June 25, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (“Lifecare” or the “Company”) on 14 June 2024 regarding the final results of the partially underwritten rights issue of new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the issuance of 59,038,955 new shares in the Rights Issue […]
Read more

LIFE – Longevity trials in dogs starts today

June 18, 2024
Bergen, Norway, 18 June 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company will starts the longevity trials in dogs today. Reference is made to stock exchange notification June 10th and June 13th, 2024. The company have improved the read-out distance […]
Read more

Lifecare ASA: Mandatory notification of trade

June 14, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Hannibal Invest AS, a company closely associated with Hans Hekland, board member of the Company, has today subscribed 12.809 shares in […]
Read more

LIFE: Satisfied with the final results of the Rights Issue

June 14, 2024
Bergen, Norway, 14 June, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that all valid subscriptions from investors with subscription rights have been allocated in accordance with the allocation criteria set out in the prospectus for the Rights Issue. Reference is made to […]
Read more